Alpa Laboratories Announces Q1 Financial Results, Receives 'Hold' Call from MarketsMOJO
Alpa Laboratories, a microcap pharmaceutical company, reported its financial results for the quarter ending March 2024. The company's Profit After Tax has increased by 21.3%, but Net Sales and Profit Before Tax have seen a significant decline. Non Operating Income is at its highest, but Cash and Cash Equivalents are at their lowest, raising concerns for the company's short-term liquidity. Investors are advised to hold their stocks and closely monitor the company's performance.
Alpa Laboratories, a microcap company in the pharmaceutical industry, recently announced its financial results for the quarter ending March 2024. The results, declared on August 13, 2024, have received a 'Hold' call from MarketsMOJO.
According to the financials, Alpa Laboratories has seen a negative performance in the quarter, with a score of -8 compared to -2 in the previous three months. However, there are some positive aspects to the company's performance. The Profit After Tax (PAT) for the quarter has grown by 21.3% to Rs 5.10 crore, compared to the average PAT of the previous four quarters at Rs 4.21 crore. This indicates a positive trend in the near term.
On the other hand, there are some areas of concern for Alpa Laboratories. The Net Sales for the quarter have fallen by -21.1% to Rs 21.44 crore, compared to the average Net Sales of the previous four quarters at Rs 27.19 crore. This shows a very negative trend in the near term. Similarly, the Profit Before Tax less Other Income (PBT) has fallen by -104.1% to Rs -0.06 crore, compared to the average PBT of the previous four quarters at Rs 1.46 crore. This is also a very negative trend in the near term.
Moreover, the company's Non Operating Income for the quarter is 101.18% of the PBT, indicating a high income from non-business activities. This may not be a sustainable business model for the company. Additionally, the Cash and Cash Equivalents for the half-yearly period are at their lowest at Rs 1.71 crore, indicating a deteriorating short-term liquidity. The Non Operating Income for the quarter is also at its highest at Rs 5.16 crore in the last five quarters, which may not be sustainable.
Overall, Alpa Laboratories has seen a mixed performance in the quarter ending March 2024. While there are some positive aspects, there are also areas of concern that the company needs to address. Investors are advised to hold their stocks and monitor the company's performance closely.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
